Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
According to the Chinese cardiovascular disease report released in 2017, cardiovascular disease death is the leading cause of death of urban and rural residents, so cardiovascular disease risk assessment is particularly important. The development of cardiovascular risk assessment model was dated from Framingham Heart Study which first proposed the concept of risk factors, and then adjusted the model several times. In 2016, the China-PAR evaluated the cardiovascular disease risk of Chinese population. However, the application of metabolomics in coronary heart disease is a rapidly developing field and also a new field .
Therefore, the aim of this study was to
1.Describe the risk factors of atherosclerotic cardiovascular disease and the characteristics of metabolomics in Chinese population.
2. Establish an accurate prediction model of atherosclerotic heart disease. Research plan:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| low risk | According to the China PAR equations and Chinese guidelines and consensus on cardiovascular risk assessment and management, it is considered as low-risk population. | ||
| medium risk | According to the China PAR equations and Chinese guidelines and consensus on cardiovascular risk assessment and management, it is considered as medium-risk population. | ||
| high risk | According to the China PAR equations and Chinese guidelines and consensus on cardiovascular risk assessment and management, it is considered as high-risk population. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Metabolomics Characterization of Biomarkers | Metabonomics analysis uses a non targeted detection method to detect polar compounds and lipid compounds in blood. The characteristic peaks of substances that can be detected are detected by chromatography Series platform, and then these characteristic peaks are compared with the standard library containing more than 8000 metabolites to annotate the compounds and screen out the differential metabolites between groups. | 3 years |
| Coronary vascularization. | Coronary vascularization includes percutaneous coronary intervention, or/and percutaneous coronary artery dilatation, or/and percutaneous coronary artery bypass grafting. | 3 years |
| All cause mortality | which refers to the total death caused by various causes in a certain period. | 3 years |
| Cardiac mortality | Cardiac death refers to the death caused by serious cardiac dysfunction or failure which caused by heart disease or injury in a certain period. | 3 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
According to China PAR equations and Chinese guidelines and consensus on cardiovascular risk assessment and management, the patients were defined as low, medium, high risk groups.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Cardiology,Shanghai Tenth People's Hospital | Not yet recruiting | Shanghai | 200072 | China |
Not provided
| ID | Term |
|---|---|
| D050197 | Atherosclerosis |
| ID | Term |
|---|---|
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
The instrument platforms of gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) are used to metabonomic analysis. Small molecular metabolites in blood were measured by LC-MS and GC-MS.The instrument platforms of GC-MS and LC-MS are used. The samples tested on GC-MS platform need to be derivatized, mainly for the detection of polar and weak polar metabolites with molecular weight not higher than 1000Da and low boiling point; LC-MS uses different liquid phase systems to detect polar and weak polar metabolites, lipids and lipid soluble metabolites respectively; The same sample needs to be detected through five data acquisition modes on three mass spectrometry platforms.
| Shanghai Tenth People's Hospital | Recruiting | Shanghai | 200072 | China |
|